{"id":"arthrotec","rwe":[],"_fda":{"id":"1e6ba7b2-299c-67cc-e063-6294a90a589d","set_id":"005299ac-b6de-511f-e063-6294a90a29e0","openfda":{"upc":["0368071345612"],"unii":["QTG126297Q"],"route":["TOPICAL"],"rxcui":["855633"],"spl_id":["1e6ba7b2-299c-67cc-e063-6294a90a589d"],"brand_name":["Diclofenac Sodium"],"spl_set_id":["005299ac-b6de-511f-e063-6294a90a29e0"],"package_ndc":["68071-3456-1"],"product_ndc":["68071-3456"],"generic_name":["DICLOFENAC SODIUM"],"product_type":["HUMAN OTC DRUG"],"substance_name":["DICLOFENAC SODIUM"],"manufacturer_name":["NuCare Pharmaceuticals,Inc."],"application_number":["ANDA211253"],"original_packager_product_ndc":["45802-953"]},"purpose":["Purpose Arthritis pain reliever"],"version":"2","stop_use":["Stop use and ask a doctor if pain gets worse or lasts more than 21 days redness or swelling is present in the painful area fever occurs skin irritation occurs any new symptoms appear. These could be signs of a serious condition. you experience any of the following signs of stomach bleeding: feel faint have bloody or black stools vomit blood have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing leg swelling weakness in one part or side of body slurred speech"],"warnings":["Warnings For external use only Allergy alert: Diclofenac may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives asthma (wheezing) skin reddening blisters facial swelling shock rash If an allergic reaction occurs, stop use and seek medical help right away. Liver warning: This product contains diclofenac. Liver damage may occur if you apply more or for a longer time than directed when using other drugs containing diclofenac Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is small but higher if you are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) have 3 or more alcoholic drinks every day while using this product apply more or for longer than directed Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use if you have ever had an allergic reaction to any other pain reliever or to a fever reducer for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries. right before or after heart surgery on more than 2 body areas at the same time in the eyes, nose or mouth Ask a doctor before us if you have problems or serious side effects from taking pain relievers or fever reducers stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you are under age 18 years. It is not known if this drug works or is safe in children under age 18 years. Ask a doctor or pharmacist before use if you are under a doctor’s care for any serious condition taking any other drug When using this product avoid contact with eyes, nose, or mouth if eye contact occurs, rinse thoroughly with water Stop use and ask a doctor if pain gets worse or lasts more than 21 days redness or swelling is present in the painful area fever occurs skin irritation occurs any new symptoms appear. These could be signs of a serious condition. you experience any of the following signs of stomach bleeding: feel faint have bloody or black stools vomit blood have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing leg swelling weakness in one part or side of body slurred speech If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use this product during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222)."],"questions":["Questions or comments ? 1-800-719-9260"],"ask_doctor":["Ask a doctor before us if you have problems or serious side effects from taking pain relievers or fever reducers stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you are under age 18 years. It is not known if this drug works or is safe in children under age 18 years."],"do_not_use":["Do not use if you have ever had an allergic reaction to any other pain reliever or to a fever reducer for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries. right before or after heart surgery on more than 2 body areas at the same time in the eyes, nose or mouth"],"when_using":["When using this product avoid contact with eyes, nose, or mouth if eye contact occurs, rinse thoroughly with water"],"effective_time":"20240729","active_ingredient":["Active ingredient Diclofenac sodium (NSAID*) 1% (equivalent to 0.93% diclofenac) *nonsteroidal anti-inflammatory drug"],"inactive_ingredient":["Inactive ingredients carbomer homopolymer Type C, cocoyl caprylocaprate, fragrance, isopropyl alcohol, mineral oil, polyoxyl 20 cetostearyl ether, propylene glycol, purified water, strong ammonia solution"],"storage_and_handling":["Other information store at 20-25°C (68-77°F). Keep from freezing. read all product information before using. Keep the dosing card, this carton and accompanying User Guide for important information."],"indications_and_usage":["Uses for the temporary relief of arthritis pain ONLY in the following areas: hand, wrist, elbow (upper body areas) foot, ankle, knee (lower body areas) this product may take up to 7 days to work for arthritis pain; it is not for immediate relief. If no pain relief in 7 days, stop use."],"ask_doctor_or_pharmacist":["Ask a doctor or pharmacist before use if you are under a doctor’s care for any serious condition taking any other drug"],"spl_unclassified_section":["Diclofenac Sodium Topical Gel, 1% (NSAID) Arthritis Pain Reliever User Guide How to use Diclofenac Sodium Topical Gel, 1% with answers to frequently asked questions Quick Start How to get started right away with Diclofenac Sodium Topical Gel, 1% Understanding Diclofenac Sodium Topical Gel, 1% Diclofenac Sodium Topical Gel, 1% (NSAID) – arthritis pain reliever is an arthritis pain relief medication that you apply to your skin. Before You Use Diclofenac Sodium Topical Gel, 1% Read the Drug Facts Label, which appears on the carton. Remove the dosing card from the inside of the carton. You should always use the dosing card to measure out the correct dose of Diclofenac Sodium Topical Gel, 1%. The first time you use a tube of Diclofenac Sodium Topical Gel, 1%: The first time you use a tube of Diclofenac Sodium Topical Gel, 1%: 1. Take the cap off the tube. 2. Open the safety seal by firmly pressing the point on the top of the cap onto the seal on the tube. Do not open the safety seal with scissors or other sharp objects. 3. After use, put the cap back on the end of the tube. Using Diclofenac Sodium Topical Gel, 1% How often to use Diclofenac Sodium Topical Gel, 1% Use 4 times a day for best results. For example: Where to apply Diclofenac Sodium Topical Gel, 1% Diclofenac Sodium Topical Gel, 1% can be used on up to 2 body areas from the following list: a hand, a wrist, an elbow, a foot, an ankle, a knee. Do not use on more than 2 body areas at once. Some examples include: Measuring the correct amount using the dosing card For each upper body area (a hand, a wrist, or an elbow): Squeeze gel from the tube equal to the length shown on the upper body section of the dosing card (2.25 inches). For each lower body area (a foot, an ankle, or a knee): Squeeze gel from the tube equal to the length shown on the lower body section of the dosing card (4.5 inches). Lost Your Dosing Card? Don’t worry! Call 1-800-719-9260 to get a free replacement. Applying Diclofenac Sodium Topical Gel, 1% Gently rub Diclofenac Sodium Topical Gel, 1% into the skin using your hand. Apply 4 times a day for best results. Do not use on more than 2 body areas at once. Apply only to clean, dry skin that doesn’t have any cuts, open wounds, infections or rashes. Do not apply in the same area as any other medicines or products that are applied to the skin. After You Use Diclofenac Sodium Topical Gel, 1% Wash your hands after applying Diclofenac Sodium Topical Gel, 1%. If the treated area is the hands wait up to 1 hour to wash the hands. Wash the dosing card with water. Store dosing card with your Diclofenac Sodium Topical Gel, 1% and keep out of reach of children. Wait ten minutes before covering the treated areas with clothes or gloves. Avoid: showering or bathing for at least 1 hour after use exposing the treated area to sunlight or artificial light (such as in tanning booths) use in same area as other products applied to the skin applying a bandage over the treated area eye, nose, or mouth contact if eye contact occurs, rinse thoroughly with water Facts you need to know Important information about Diclofenac Sodium Topical Gel, 1% Do not use Diclofenac Sodium Topical Gel, 1%... if you have ever had an allergic reaction to any other pain reliever or to a fever reducer for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries. right before or after heart surgery on more than 2 body areas at the same time in the eyes, nose or mouth Ask a doctor before use if... you have problems or serious side effects from taking pain relievers or fever reducers stomach bleeding warning applies to you you have a history of stomach problems such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you are under age 18 years. It is not known if this drug works or is safe in children under age 18 years. Ask a doctor or pharmacist before use if... you are under a doctor’s care for any serious condition you are taking any other drug you are pregnant or breast-feeding It is especially important not to use this product during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery. Warnings to consider before use... Allergy alert Diclofenac may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives blisters asthma (wheezing) facial swelling skin reddening shock rash If an allergic reaction occurs, stop use and seek medical help right away. Liver warning This product contains diclofenac. Liver damage may occur if you apply more or for a longer time than directed when using other drugs containing diclofenac Stomach bleeding warning This product contains an NSAID, which may cause stomach bleeding. The chance is small but higher if you are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) have 3 or more alcoholic drinks every day while using this product apply more or for longer than directed Heart attack and stroke warning NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. This can be fatal. The risk is higher if you use more than directed or for longer than directed. Follow these important guidelines when using Diclofenac Sodium Topical Gel, 1%... use only as directed apply only to clean, dry skin that does not have any cuts, open wounds, infections or rashes do not apply in the same area as any other product used on the skin do not apply with external heat such as heating pad do not apply a bandage over the treated area do not get gel in eyes, nose or mouth store ENCLOSED DOSING CARD with your Diclofenac Sodium Topical Gel, 1%. The dosing card is re-usable. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222). Stop using Diclofenac Sodium Topical Gel, 1% and ask a doctor if... pain gets worse or lasts more than 21 days redness or swelling is present in the painful area fever occurs skin irritation occurs any new symptoms appear. These could be signs of a serious condition. you experience any of the following signs of stomach bleeding: feel faint have bloody or black stools vomit blood have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing leg swelling weakness in one part of side of body slurred speech Questions and Answers Answers to questions you may ask about Diclofenac Sodium Topical Gel, 1% Can I use Diclofenac Sodium Topical Gel, 1% for the immediate relief of pain like that associated with sprains, strains, bruises, or sports injuries? No. Do not use for strains, sprains, bruises, or sports injuries. This product has not been shown to work for these types of injuries. It’s intended only for the temporary relief of arthritis pain. How quickly will Diclofenac Sodium Topical Gel, 1% work for arthritis pain? Diclofenac Sodium Topical Gel, 1% may take up to 7 days to work for your arthritis pain; it is not for immediate relief. With 4 times-a-day use, you may start to feel relief within a few days. You should feel significant pain relief within 7 days of continuous use. If no pain relief in 7 days, stop use. What is Diclofenac Sodium Topical Gel, 1% used for? Diclofenac Sodium Topical Gel, 1% can be used for the temporary relief of arthritis pain in the hands, wrists, elbows, feet, ankles, and knees. Osteoarthritis (OA) is the most common form of arthritis. It mainly affects a type of tissue called cartilage, which cushions the joints and prevents the bones from rubbing against each other. With OA, cartilage begins to break down and wear away, resulting in joint pain and stiffness. OA occurs more frequently as you get older. Pain develops slowly and can gradually worsen over time. How does Diclofenac Sodium Topical Gel, 1% work? Diclofenac sodium, the medicine in Diclofenac Sodium Topical Gel, 1%, is a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs are used to treat pain from medical conditions such as arthritis. Diclofenac Sodium Topical Gel, 1% works similarly to oral NSAIDs like ibuprofen or naproxen by temporarily blocking the production of pain signaling chemicals called prostaglandins. However, when taking a pill, the medication is distributed to the site of pain through the bloodstream. Compared to oral diclofenac, only 6% of the medicine in Diclofenac Sodium Topical Gel, 1% is absorbed in the bloodstream. It works by penetrating through your skin at the application site to deliver arthritis pain relief. How does over-the-counter Diclofenac Sodium Topical Gel, 1% differ from prescription Diclofenac Sodium Topical Gel, 1%? Over-the-counter Diclofenac Sodium Topical Gel, 1% is the same strength and formula as original full prescription strength Diclofenac Sodium Topical Gel, 1% but is available without a prescription. Apply Diclofenac Sodium Topical Gel, 1% 4 times a day to ensure you get the full effect of the medicine. Can I apply Diclofenac Sodium Topical Gel, 1% to upper and lower body areas at the same time? Yes. You can use Diclofenac Sodium Topical Gel, 1% on up to 2 body areas at the same time. The areas can include the foot, ankle, knee, hand, wrist, and elbow. Some correct examples include: Do not use Diclofenac Sodium Topical Gel, 1% on more than 2 body areas at once. Can I apply Diclofenac Sodium Topical Gel, 1% without measuring it out on the dosing card first? No. Use the dosing card to make sure you are getting the correct amount of medicine. Can I use Diclofenac Sodium Topical Gel, 1% on my spine, hips, or shoulders? No. The use of Diclofenac Sodium Topical Gel, 1% on the spine, hips, and shoulders has not been studied. Can I take any other pain medications with Diclofenac Sodium Topical Gel, 1%? Ask your doctor or pharmacist before using Diclofenac Sodium Topical Gel, 1% if you are taking any other pain reliever or are planning on taking any other pain reliever, especially prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others). Can I take any other pain medications during the first 7 days I use Diclofenac Sodium Topical Gel, 1%? Taking other pain medications is generally not recommended. Speak with your doctor or pharmacist before taking other pain medications when using Diclofenac Sodium Topical Gel, 1%. How long can I use Diclofenac Sodium Topical Gel, 1%? Use Diclofenac Sodium Topical Gel, 1% 4 times a day every day for up to 21 days for treatment of arthritis pain or as directed by your doctor. Diclofenac Sodium Topical Gel, 1% should be part of an overall program for managing your arthritis pain. The program should also include activities such as appropriate movement or exercise, specific lifestyle changes, and weight maintenance. Regular visits and discussions with your doctor can help incorporate Diclofenac Sodium Topical Gel, 1% into a complete program to help manage your arthritis pain. What do I do if I get Diclofenac Sodium Topical Gel, 1% in my eyes? If eye contact occurs, rinse thoroughly with water and consult a doctor if irritation lasts more than an hour. How do I clean the dosing card? Wash the dosing card with water, and store dosing card and tube out of reach of children. What if I miss a dose of Diclofenac Sodium Topical Gel, 1%? If you forget to apply Diclofenac Sodium Topical Gel, 1% don’t double your dose. Just apply the next dose as scheduled. How should I store Diclofenac Sodium Topical Gel, 1%? Store at 20-25°C (68-77°F). Do not freeze Diclofenac Sodium Topical Gel, 1%. Store the dosing card with your Diclofenac Sodium Topical Gel, 1%. Keep out of reach of children. Additional Questions? Call 1-800-719-9260. Made in Israel Distributed By Perrigo® Allegan, MI 49010 87A00 00 J1 Hands opening package Opening Tube Remove cap Replace cap How often to use where to apply measure using dosing card measure using dosing card Apply to areas wash your hands wash the dosing card wait 10 minutes cartilage correct examples"],"dosage_and_administration":["Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries. Daily Per Dose For your arthritis pain: Use 4 times per day every day Do not use on more than 2 body areas at the same time Use ENCLOSED DOSING CARD to measure a dose For each upper body area (hand, wrist, or elbow) – Squeeze out 2.25 inches (2 grams) For each lower body area (foot, ankle or knee) –Squeeze out 4.5 inches (4 grams) Read the enclosed User Guide for complete instructions: use only as directed do not use more than directed or for longer than directed apply only to clean, dry skin that does not have any cuts, open wounds, infections or rashes do not apply in same area as any other product do not apply with external heat such as heating pad do not apply a bandage over the treated area store ENCLOSED DOSING CARD with your Diclofenac Sodium Topical Gel, 1% product. The dosing card is re-usable."],"spl_product_data_elements":["Diclofenac Sodium diclofenac sodium CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) COCO-CAPRYLATE/CAPRATE ISOPROPYL ALCOHOL MINERAL OIL POLYOXYL 20 CETOSTEARYL ETHER PROPYLENE GLYCOL WATER DICLOFENAC SODIUM DICLOFENAC"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use this product during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery."],"keep_out_of_reach_of_children":["Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222)."],"dosage_and_administration_table":["
DailyPer Dose
For your arthritis pain:Use 4 times per day every dayDo not use on more than 2 body areas at the same timeUse ENCLOSED DOSING CARD to measure a doseFor each upper body area (hand, wrist, or elbow) – Squeeze out 2.25 inches (2 grams)For each lower body area (foot, ankle or knee) –Squeeze out 4.5 inches (4 grams)
"],"package_label_principal_display_panel":["Package/Label Principal Display Panel pdp"]},"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"30209 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"15146 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"13334 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"12926 reports"},{"date":"","signal":"PRODUCT USE IN UNAPPROVED INDICATION","source":"FDA FAERS","actionTaken":"12884 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"10863 reports"},{"date":"","signal":"RASH","source":"FDA FAERS","actionTaken":"10363 reports"},{"date":"","signal":"RHEUMATOID ARTHRITIS","source":"FDA FAERS","actionTaken":"10349 reports"},{"date":"","signal":"ABDOMINAL DISCOMFORT","source":"FDA FAERS","actionTaken":"9298 reports"},{"date":"","signal":"PRODUCT USE ISSUE","source":"FDA FAERS","actionTaken":"9048 reports"}],"drugInteractions":[{"name":"dicoumarol","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/DICUMAROL [VA Drug Interaction]"},{"name":"fluconazole","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/FLUCONAZOLE [VA Drug Interaction]"},{"name":"lithium","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/LITHIUM [VA Drug Interaction]"},{"name":"methotrexate","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/METHOTREXATE [VA Drug Interaction]"},{"name":"phenprocoumon","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/PHENPROCOUMON [VA Drug Interaction]"},{"name":"voriconazole","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/VORICONAZOLE [VA Drug Interaction]"},{"name":"warfarin","source":"DrugCentral","severity":"Significant","description":"DICLOFENAC/WARFARIN [VA Drug Interaction]"}],"commonSideEffects":[{"effect":"Abdominal pain","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Heartburn","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Headaches","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Constipation","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Rashes","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Elevated liver enzymes","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Abnormal renal function","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Flatulence","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Increased bleeding time","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Tinnitus","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"GI ulcers","drugRate":"5.5%","severity":"common","organSystem":""},{"effect":"Gross bleeding/perforation","drugRate":"5.5%","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Alcoholism","Anemia","Asthenia","Asthma","Blood coagulation disorder","Bloody Vomit","Body fluid retention","Cardiovascular event risk","Cerebrovascular accident","Chronic heart failure","Corneal Infiltrates","Corneal degeneration","Corneal erosion","Corneal ulcer","Coronary artery bypass graft","Dehydration","Deliveries by cesarean","Diabetes mellitus","Disease of liver"],"specialPopulations":{"Pregnancy":"ARTHROTEC is contraindicated in pregnant women. If a woman becomes pregnant while taking ARTHROTEC, discontinue the drug and advise the woman of the potential risks to her and to a fetus. Misoprostol may produce uterine contractions, uterine bleeding, and expulsion of the products of conception. Uterine rupture, amniotic fluid embolism, severe bleeding, shock, and maternal death have been reported when misoprostol was administered to pregnant women to induce labor to induce abortion beyond the eighth week of pregnancy.","Geriatric use":"Avoid use in patients with cardiovascular and/or renal risk factors.","Paediatric use":"No information available.","Renal impairment":"Avoid use in patients with advanced renal disease.","Hepatic impairment":"No information available."},"seriousAdverseEvents":[{"effect":"Anaphylactic reactions","drugRate":"","severity":"serious"},{"effect":"Stevens-Johnson syndrome","drugRate":"","severity":"serious"},{"effect":"Toxic epidermal necrolysis","drugRate":"","severity":"serious"},{"effect":"Liver failure","drugRate":"","severity":"serious"},{"effect":"Fulminant hepatitis","drugRate":"","severity":"serious"},{"effect":"Myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Renal failure","drugRate":"","severity":"serious"},{"effect":"Interstitial nephritis","drugRate":"","severity":"serious"},{"effect":"Aplastic anemia","drugRate":"","severity":"serious"},{"effect":"Agranulocytosis","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"company":"Pfizer","patents":[{"source":"DrugCentral Orange Book","expires":"2035-02-20","patentNumber":"11344520"},{"source":"DrugCentral Orange Book","expires":"2035-02-20","patentNumber":"11351133"},{"source":"DrugCentral Orange Book","expires":"2030-08-09","patentNumber":"8546450"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"8679544"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"8999387"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"9017721"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"9173854"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"9180095"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"9180096"},{"source":"DrugCentral Orange Book","expires":"2030-04-23","patentNumber":"9186328"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"8217078"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"8618164"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"8741956"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"9370501"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"9375412"},{"source":"DrugCentral Orange Book","expires":"2029-07-10","patentNumber":"9415029"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"7662858"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"7884095"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"7939518"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"8110606"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"8623920"},{"source":"DrugCentral Orange Book","expires":"2029-02-24","patentNumber":"9561200"},{"source":"DrugCentral Orange Book","expires":"2028-04-21","patentNumber":"8252838"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"8563613"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"8871809"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9066913"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9101591"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9132110"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9168304"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9168305"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9220784"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9339551"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9339552"},{"source":"DrugCentral Orange Book","expires":"2027-10-17","patentNumber":"9539335"},{"source":"DrugCentral Orange Book","expires":"2027-03-22","patentNumber":"8946292"},{"source":"DrugCentral Orange Book","expires":"2026-06-16","patentNumber":"7759394"},{"source":"DrugCentral Orange Book","expires":"2026-06-16","patentNumber":"8097651"},{"source":"DrugCentral Orange Book","expires":"2026-06-16","patentNumber":"8927604"},{"source":"DrugCentral Orange Book","expires":"2026-06-16","patentNumber":"9827197"}],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$1.9196/ML","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$691","description":"DICLOFENAC 0.1% EYE DROPS","retrievedDate":"2026-04-07"}],"_recalls":[{"date":"20120620","reason":"Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.","classification":"Class II"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Diclofenac Sodium","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:38:56.494931+00:00"},"patents":{"url":"","method":"deterministic","source":"FDA Orange Book","rawText":"","confidence":1,"sourceType":"fda_orange_book","retrievedAt":"2026-04-19T23:38:56.494378+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Diclofenac Sodium","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-19T23:39:05.831661+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:39:03.673067+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:38:56.514364+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-19T23:38:54.246807+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Diclofenac Sodium","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:39:04.587419+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:38:53.061101+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:38:53.061165+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T23:39:06.860282+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:39:05.831350+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1034/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:39:05.717595+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"ANDA211253","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:38:53.061175+00:00"}},"offLabel":[],"synonyms":["diclofenac calcium","diclofenac diethylamine","diclofenac hydroxyethylpyrrolidine","diclofenac","diclofenamic acid","diclofenac sodium","diclofenac potassium","diclofenac epolamine"],"timeline":[{"date":"1996-03-26","type":"positive","_source":"FDA ANDA074514","milestone":"FDA ORIG — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"1997-12-24","type":"positive","_source":"FDA NDA020607","milestone":"FDA ORIG — PFIZER","regulator":"FDA","description":""},{"date":"1998-03-12","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"1998-03-16","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"1998-11-13","type":"positive","_source":"FDA ANDA075185","milestone":"FDA ORIG — CARLSBAD","regulator":"FDA","description":""},{"date":"1999-02-22","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2000-02-11","type":"positive","_source":"FDA ANDA075492","milestone":"FDA ORIG — VPNA","regulator":"FDA","description":""},{"date":"2000-06-02","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2000-10-03","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2001-02-16","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2001-06-08","type":"positive","_source":"FDA ANDA075492","milestone":"FDA SUPPL — VPNA","regulator":"FDA","description":""},{"date":"2002-02-12","type":"positive","_source":"FDA ANDA075281","milestone":"FDA ORIG — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2002-02-21","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2002-05-20","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2002-11-06","type":"positive","_source":"FDA ANDA076201","milestone":"FDA ORIG — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2003-10-23","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2003-11-19","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2004-02-20","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2005-07-08","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2006-01-25","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2006-02-23","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2006-03-13","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2006-07-28","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2007-01-08","type":"positive","_source":"FDA ANDA075492","milestone":"FDA SUPPL — VPNA","regulator":"FDA","description":""},{"date":"2007-06-08","type":"positive","_source":"FDA ANDA077863","milestone":"FDA ORIG — UNIQUE","regulator":"FDA","description":""},{"date":"2007-08-24","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2007-10-17","type":"positive","_source":"FDA NDA022122","milestone":"FDA ORIG — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2007-12-20","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2007-12-28","type":"positive","_source":"FDA ANDA078792","milestone":"FDA ORIG — BAUSCH AND LOMB","regulator":"FDA","description":""},{"date":"2008-02-06","type":"positive","_source":"FDA ANDA078031","milestone":"FDA ORIG — SANDOZ","regulator":"FDA","description":""},{"date":"2008-05-08","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2008-11-13","type":"positive","_source":"FDA ANDA077600","milestone":"FDA ORIG — RUBICON RESEARCH","regulator":"FDA","description":""},{"date":"2009-02-25","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2009-05-11","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2009-07-31","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2009-08-04","type":"positive","_source":"FDA ANDA077863","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2009-09-04","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2010-02-18","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2010-03-19","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2010-07-06","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2010-07-30","type":"positive","_source":"FDA ANDA075492","milestone":"FDA SUPPL — VPNA","regulator":"FDA","description":""},{"date":"2010-12-01","type":"positive","_source":"FDA ANDA090066","milestone":"FDA ORIG — UNIQUE","regulator":"FDA","description":""},{"date":"2010-12-07","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2010-12-21","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2011-03-17","type":"positive","_source":"FDA ANDA077863","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2012-07-09","type":"positive","_source":"FDA ANDA201089","milestone":"FDA ORIG — ACTAVIS LABS FL INC","regulator":"FDA","description":""},{"date":"2013-02-08","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2013-09-30","type":"positive","_source":"FDA ANDA078792","milestone":"FDA SUPPL — BAUSCH AND LOMB","regulator":"FDA","description":""},{"date":"2013-10-28","type":"positive","_source":"FDA ANDA200936","milestone":"FDA ORIG — AMNEAL","regulator":"FDA","description":""},{"date":"2014-05-27","type":"positive","_source":"FDA ANDA202027","milestone":"FDA ORIG — APOTEX","regulator":"FDA","description":""},{"date":"2014-09-03","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2014-09-29","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2014-10-15","type":"positive","_source":"FDA ANDA090066","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2014-11-07","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2014-11-26","type":"positive","_source":"FDA ANDA203818","milestone":"FDA ORIG — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2014-11-28","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2014-12-14","type":"positive","_source":"FDA ANDA077600","milestone":"FDA SUPPL — RUBICON RESEARCH","regulator":"FDA","description":""},{"date":"2014-12-14","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2015-04-01","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2015-05-11","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2015-08-20","type":"positive","_source":"FDA ANDA204132","milestone":"FDA ORIG — LUPIN LTD","regulator":"FDA","description":""},{"date":"2015-08-24","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2015-09-16","type":"positive","_source":"FDA ANDA201089","milestone":"FDA SUPPL — ACTAVIS LABS FL INC","regulator":"FDA","description":""},{"date":"2015-11-16","type":"positive","_source":"FDA ANDA203383","milestone":"FDA ORIG — ALTAIRE PHARMS INC","regulator":"FDA","description":""},{"date":"2015-12-02","type":"positive","_source":"FDA ANDA206493","milestone":"FDA ORIG — ACTAVIS MID ATLANTIC","regulator":"FDA","description":""},{"date":"2015-12-09","type":"positive","_source":"FDA ANDA205878","milestone":"FDA ORIG — NOVEL LABS INC","regulator":"FDA","description":""},{"date":"2016-03-18","type":"positive","_source":"FDA ANDA208077","milestone":"FDA ORIG — AMNEAL PHARMS","regulator":"FDA","description":""},{"date":"2016-04-28","type":"positive","_source":"FDA ANDA206298","milestone":"FDA ORIG — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA ANDA077863","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2016-05-09","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2016-09-13","type":"positive","_source":"FDA ANDA208301","milestone":"FDA ORIG — GLENMARK PHARMS LTD","regulator":"FDA","description":""},{"date":"2017-10-20","type":"positive","_source":"FDA ANDA202027","milestone":"FDA SUPPL — APOTEX","regulator":"FDA","description":""},{"date":"2018-02-21","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2018-07-27","type":"positive","_source":"FDA ANDA210893","milestone":"FDA ORIG — PADAGIS ISRAEL","regulator":"FDA","description":""},{"date":"2018-08-03","type":"positive","_source":"FDA ANDA209903","milestone":"FDA ORIG — CIPLA","regulator":"FDA","description":""},{"date":"2019-05-06","type":"positive","_source":"FDA ANDA204306","milestone":"FDA ORIG — AUROLIFE PHARMA LLC","regulator":"FDA","description":""},{"date":"2019-05-16","type":"positive","_source":"FDA ANDA211253","milestone":"FDA ORIG — PERRIGO PHARMA INTL","regulator":"FDA","description":""},{"date":"2020-01-27","type":"positive","_source":"FDA ANDA210986","milestone":"FDA ORIG — ENCUBE","regulator":"FDA","description":""},{"date":"2020-02-14","type":"positive","_source":"FDA ANDA204132","milestone":"FDA SUPPL — LUPIN LTD","regulator":"FDA","description":""},{"date":"2020-02-14","type":"positive","_source":"FDA ANDA205878","milestone":"FDA SUPPL — NOVEL LABS INC","regulator":"FDA","description":""},{"date":"2020-02-14","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2020-02-19","type":"positive","_source":"FDA ANDA205143","milestone":"FDA ORIG — YUNG SHIN PHARM","regulator":"FDA","description":""},{"date":"2020-04-01","type":"positive","_source":"FDA ANDA211253","milestone":"FDA SUPPL — PERRIGO PHARMA INTL","regulator":"FDA","description":""},{"date":"2020-07-28","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2020-08-06","type":"positive","_source":"FDA ANDA204306","milestone":"FDA SUPPL — AUROLIFE PHARMA LLC","regulator":"FDA","description":""},{"date":"2020-08-11","type":"positive","_source":"FDA ANDA210986","milestone":"FDA SUPPL — ENCUBE","regulator":"FDA","description":""},{"date":"2020-08-13","type":"positive","_source":"FDA ANDA208077","milestone":"FDA SUPPL — AMNEAL PHARMS","regulator":"FDA","description":""},{"date":"2021-03-26","type":"positive","_source":"FDA ANDA075492","milestone":"FDA SUPPL — VPNA","regulator":"FDA","description":""},{"date":"2021-03-29","type":"positive","_source":"FDA ANDA077863","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2021-03-29","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2021-03-31","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2021-04-02","type":"positive","_source":"FDA ANDA203818","milestone":"FDA SUPPL — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2021-04-20","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2021-04-28","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2021-04-28","type":"positive","_source":"FDA ANDA204132","milestone":"FDA SUPPL — LUPIN LTD","regulator":"FDA","description":""},{"date":"2021-04-28","type":"positive","_source":"FDA ANDA205878","milestone":"FDA SUPPL — NOVEL LABS INC","regulator":"FDA","description":""},{"date":"2021-04-28","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2021-04-28","type":"positive","_source":"FDA ANDA202027","milestone":"FDA SUPPL — APOTEX","regulator":"FDA","description":""},{"date":"2021-04-29","type":"positive","_source":"FDA ANDA206116","milestone":"FDA SUPPL — AMNEAL PHARMS","regulator":"FDA","description":""},{"date":"2021-07-15","type":"positive","_source":"FDA ANDA204355","milestone":"FDA ORIG — MICRO LABS","regulator":"FDA","description":""},{"date":"2021-07-19","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2022-05-06","type":"positive","_source":"FDA ANDA207714","milestone":"FDA ORIG — APOTEX","regulator":"FDA","description":""},{"date":"2022-07-27","type":"positive","_source":"FDA ANDA212351","milestone":"FDA ORIG — ALEMBIC","regulator":"FDA","description":""},{"date":"2022-08-18","type":"positive","_source":"FDA ANDA208198","milestone":"FDA ORIG — AMNEAL","regulator":"FDA","description":""},{"date":"2022-08-26","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2022-09-21","type":"positive","_source":"FDA ANDA208021","milestone":"FDA ORIG — LUPIN PHARMS","regulator":"FDA","description":""},{"date":"2022-09-23","type":"positive","_source":"FDA ANDA216275","milestone":"FDA ORIG — INGENUS PHARMS LLC","regulator":"FDA","description":""},{"date":"2022-09-28","type":"positive","_source":"FDA ANDA211253","milestone":"FDA SUPPL — PERRIGO PHARMA INTL","regulator":"FDA","description":""},{"date":"2022-09-29","type":"positive","_source":"FDA ANDA208098","milestone":"FDA ORIG — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2022-11-23","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2023-02-03","type":"positive","_source":"FDA ANDA213040","milestone":"FDA ORIG — AUROLIFE PHARMA LLC","regulator":"FDA","description":""},{"date":"2023-02-21","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2023-05-10","type":"positive","_source":"FDA ANDA204306","milestone":"FDA SUPPL — AUROLIFE PHARMA LLC","regulator":"FDA","description":""},{"date":"2023-05-11","type":"positive","_source":"FDA ANDA216548","milestone":"FDA ORIG — RUBICON RESEARCH","regulator":"FDA","description":""},{"date":"2023-06-09","type":"positive","_source":"FDA ANDA208301","milestone":"FDA SUPPL — GLENMARK PHARMS LTD","regulator":"FDA","description":""},{"date":"2023-07-28","type":"positive","_source":"FDA ANDA206298","milestone":"FDA SUPPL — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2023-09-12","type":"positive","_source":"FDA ANDA212351","milestone":"FDA SUPPL — ALEMBIC","regulator":"FDA","description":""},{"date":"2024-03-01","type":"positive","_source":"FDA ANDA076201","milestone":"FDA SUPPL — DEXCEL LTD","regulator":"FDA","description":""},{"date":"2024-03-21","type":"positive","_source":"FDA ANDA205143","milestone":"FDA SUPPL — YUNG SHIN PHARM","regulator":"FDA","description":""},{"date":"2024-03-29","type":"positive","_source":"FDA ANDA204355","milestone":"FDA SUPPL — MICRO LABS","regulator":"FDA","description":""},{"date":"2024-05-13","type":"positive","_source":"FDA ANDA210893","milestone":"FDA SUPPL — PADAGIS ISRAEL","regulator":"FDA","description":""},{"date":"2024-07-11","type":"positive","_source":"FDA ANDA074514","milestone":"FDA SUPPL — ACTAVIS ELIZABETH","regulator":"FDA","description":""},{"date":"2024-07-15","type":"positive","_source":"FDA ANDA209903","milestone":"FDA SUPPL — CIPLA","regulator":"FDA","description":""},{"date":"2024-08-07","type":"positive","_source":"FDA NDA022122","milestone":"FDA SUPPL — HALEON US HOLDINGS","regulator":"FDA","description":""},{"date":"2024-09-26","type":"positive","_source":"FDA ANDA077863","milestone":"FDA SUPPL — UNIQUE","regulator":"FDA","description":""},{"date":"2024-11-18","type":"positive","_source":"FDA ANDA200936","milestone":"FDA SUPPL — AMNEAL","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA NDA020607","milestone":"FDA SUPPL — PFIZER","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA075185","milestone":"FDA SUPPL — CARLSBAD","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA204132","milestone":"FDA SUPPL — LUPIN LTD","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA206116","milestone":"FDA SUPPL — AMNEAL PHARMS","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA203818","milestone":"FDA SUPPL — SUN PHARMA CANADA","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA213040","milestone":"FDA SUPPL — AUROLIFE PHARMA LLC","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA207714","milestone":"FDA SUPPL — APOTEX","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA212351","milestone":"FDA SUPPL — ALEMBIC","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA205878","milestone":"FDA SUPPL — NOVEL LABS INC","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA075492","milestone":"FDA SUPPL — VPNA","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA216548","milestone":"FDA SUPPL — RUBICON RESEARCH","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA208301","milestone":"FDA SUPPL — GLENMARK PHARMS LTD","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA208021","milestone":"FDA SUPPL — LUPIN PHARMS","regulator":"FDA","description":""},{"date":"2024-11-21","type":"positive","_source":"FDA ANDA216275","milestone":"FDA SUPPL — INGENUS PHARMS LLC","regulator":"FDA","description":""},{"date":"2025-02-27","type":"positive","_source":"FDA ANDA204355","milestone":"FDA SUPPL — MICRO LABS","regulator":"FDA","description":""},{"date":"2025-03-31","type":"positive","_source":"FDA ANDA203995","milestone":"FDA SUPPL — AMNEAL PHARMS","regulator":"FDA","description":""},{"date":"2025-04-09","type":"positive","_source":"FDA ANDA217646","milestone":"FDA ORIG — ENCUBE","regulator":"FDA","description":""},{"date":"2025-05-21","type":"positive","_source":"FDA ANDA206493","milestone":"FDA SUPPL — ACTAVIS MID ATLANTIC","regulator":"FDA","description":""},{"date":"2025-09-26","type":"positive","_source":"FDA ANDA210986","milestone":"FDA SUPPL — ENCUBE","regulator":"FDA","description":""},{"date":"2025-11-05","type":"positive","_source":"FDA ANDA219945","milestone":"FDA ORIG — UMEDICA","regulator":"FDA","description":""},{"date":"2025-12-31","type":"positive","_source":"FDA ANDA075281","milestone":"FDA SUPPL — AUROBINDO PHARMA USA","regulator":"FDA","description":""}],"_dailymed":{"setId":"0d6509a1-7af8-473b-8951-c19439274379","title":"DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL (DICLOFENAC SODIUM/MISOPROSTOL) TABLET [SPORTPHARM LLC]","labeler":""},"aiSummary":"Arthrotec, a combination medication by Pfizer Inc., is a fixed-dose combination of diclofenac sodium and misoprostol. It works by inhibiting prostaglandin synthesis and increasing bicarbonate and mucus production. The medication is used to treat actinic keratosis, adhesive capsulitis of the shoulder, analgesia in various types of cancer, ankylosing spondylitis, and dysmenorrhea. Arthrotec's unique combination of diclofenac and misoprostol provides clinical differentiation by reducing the risk of gastric and duodenal ulcers. This makes it a commercially significant medication in the market. There are no notable pipeline developments for Arthrotec.","brandName":"Arthrotec","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Acid-sensing ion channel 3","novelty":"Best-in-class","targets":[{"gene":"ASIC3","source":"DrugCentral","target":"Acid-sensing ion channel 3","protein":"Acid-sensing ion channel 3","activityType":"IC50"},{"gene":"AKR1B10","source":"DrugCentral","target":"Aldo-keto reductase family 1 member B10","protein":"Aldo-keto reductase family 1 member B10","activityType":"IC50"},{"gene":"AKR1C3","source":"DrugCentral","target":"Aldo-keto reductase family 1 member C3","protein":"Aldo-keto reductase family 1 member C3","activityType":"IC50"},{"gene":"CXCR1","source":"DrugCentral","target":"C-X-C chemokine receptor type 1","protein":"C-X-C chemokine receptor type 1","activityType":"IC50"},{"gene":"MT-CO2","source":"DrugCentral","target":"Cytochrome c oxidase subunit 2","protein":"Cytochrome c oxidase subunit 2","activityType":"IC50"},{"gene":"CXCL8","source":"DrugCentral","target":"Interleukin-8","protein":"Interleukin-8","activityType":"IC50"},{"gene":"PPARG","source":"DrugCentral","target":"Peroxisome proliferator-activated receptor gamma","protein":"Peroxisome proliferator-activated receptor gamma","activityType":"Ki"},{"gene":"PTGS1","source":"DrugCentral","target":"Prostaglandin G/H synthase 1","protein":"Prostaglandin G/H synthase 1","activityType":"IC50"},{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2","activityType":"IC50"},{"gene":"TRPA1","source":"DrugCentral","target":"Transient receptor potential cation channel subfamily A member 1","protein":"Transient receptor potential cation channel subfamily A member 1","activityType":"EC50"}],"modality":"Small molecule","drugClass":"diclofenac","explanation":"","oneSentence":"","technicalDetail":"Diclofenac sodium inhibits cyclooxygenase (COX-1 and COX-2) enzymes, which are responsible for the production of prostaglandins. Misoprostol, a synthetic PGE1 analog, has gastric antisecretory and mucosal protective properties. It increases bicarbonate and mucus production, but also has antisecretory effects at doses above 200 mcg."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"_wikipedia":{"title":"Diclofenac/misoprostol","extract":"Diclofenac/misoprostol, sold under the brand name Arthrotec, is a fixed-dose combination medication that contains:Diclofenac sodium: Nonsteroidal anti-inflammatory drug (NSAID) with analgesic properties\nMisoprostol: Gastrointestinal (GI) mucosal protective prostaglandin E1 analog."},"commercial":{"launchDate":"1988","annualCostUS":"Not available","_launchSource":"DrugCentral (FDA 1988-07-28, )","genericStatus":"Generic — off-patent","currentRevenue":"Not available","manufacturerCount":"9 approved manufacturers","patientPopulation":"Not available","peakSalesEstimate":"Not available"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/865","fields":["approvals","synonyms","ATC","pharmacokinetics","patents","indications","contraindications","interactions","targets"],"source":"DrugCentral"},{"id":2,"url":"https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Diclofenac Sodium","fields":["mechanism","safety","indications","administration"],"source":"FDA Drug Label (DailyMed)"},{"id":3,"url":"https://clinicaltrials.gov/search?intr=Diclofenac%20Sodium","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":4,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Diclofenac Sodium","fields":["publications"],"source":"PubMed/NCBI"},{"id":5,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":6,"url":"https://en.wikipedia.org/wiki/Diclofenac Sodium","fields":["history","overview"],"source":"Wikipedia"},{"id":7,"url":"https://www.accessdata.fda.gov/scripts/cder/daf/","fields":["timeline","launchDate"],"source":"FDA Drugs@FDA"},{"id":8,"url":"https://open.fda.gov/apis/drug/event/","fields":["safetySignals"],"source":"FDA FAERS"},{"id":9,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":10,"url":"https://www.whocc.no/atc_ddd_index/","fields":["classification"],"source":"WHO ATC/DDD Index"},{"id":11,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"},{"id":12,"url":"https://www.accessdata.fda.gov/scripts/cder/daf/","fields":["genericManufacturers"],"source":"FDA Drugs@FDA (ANDA/BLA)"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:39:08.661369+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Diclofenac Sodium/Misoprostol DICLOFENAC-SODIUM-MISOPROSTOL","slug":"diclofenac-sodium/misoprostol","company":"Sportpharm LLC","advantage":"Same class (Prostaglandin E1 Analog [EPC])","genericName":"DICLOFENAC SODIUM/MISOPROSTOL"},{"name":"Diclofenac sodium and Misoprostol DR","slug":"diclofenac-sodium-and-misoprostol","company":"Advanced Rx Pharmacy of Tennessee, LLC","advantage":"Same class (Prostaglandin E1 Analog [EPC])","genericName":"DICLOFENAC SODIUM AND MISOPROSTOL"},{"name":"Misoprostol","slug":"misoprostol","company":"Lupin Pharmaceuticals,Inc.","advantage":"Same class (Prostaglandin E1 Analog [EPC])","genericName":"MISOPROSTOL"},{"name":"Tobcharm Toenail Fungus Treatment Liquid","slug":"toenail-fungus-treatment-liquid","company":"Guangzhou Qiexiran Cosmetics Co., Ltd.","advantage":"Same class (Prostaglandin E1 Analog [EPC])","genericName":"TOENAIL FUNGUS TREATMENT LIQUID"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"},{"url":"https://tavily.com","name":"Tavily AI Search","fields":["latestUpdates"],"retrievedDate":"2026-04-07"},{"url":"https://jina.ai/reader","name":"Jina Reader","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"},{"url":"https://groq.com","name":"Groq (Llama 3.1 8B)","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"}],"genericName":"diclofenac sodium","indications":{"approved":[{"name":"Actinic keratosis","source":"DrugCentral","snomedId":201101007,"regulator":"FDA"},{"name":"Adhesive capsulitis of shoulder","source":"DrugCentral","snomedId":399114005,"regulator":"FDA"},{"name":"Analgesia in various types of cancer","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Ankylosing spondylitis","source":"DrugCentral","snomedId":9631008,"regulator":"FDA"},{"name":"Dysmenorrhea","source":"DrugCentral","snomedId":266599000,"regulator":"FDA"},{"name":"Lumbago","source":"DrugCentral","snomedId":279039007,"regulator":"FDA"},{"name":"Neckshoulderarm syndrome","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Osteoarthritis","source":"DrugCentral","snomedId":396275006,"regulator":"FDA"},{"name":"Osteoarthritis in Patients at High Ulcer Risk","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Osteoarthrosis of the Knee","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Pain","source":"DrugCentral","snomedId":22253000,"regulator":"FDA"},{"name":"Post-Op Ocular Inflammation","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Post-Op Photophobia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Postoperative Ocular Pain","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Rheumatoid Arthritis in Patient at High Ulcer Risk","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Rheumatoid arthritis","source":"DrugCentral","snomedId":69896004,"regulator":"FDA"},{"name":"Sprains and Strains","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Tenosynovitis","source":"DrugCentral","snomedId":67801009,"regulator":"FDA"}],"offLabel":[{"name":"Bursitis","source":"DrugCentral"},{"name":"Cystoid macular edema","source":"DrugCentral"},{"name":"Prevention of Ocular Surgery-Induced Miosis","source":"DrugCentral"},{"name":"Renal colic","source":"DrugCentral"},{"name":"Tendinitis","source":"DrugCentral"}]},"_drugCentral":{"patents":[{"number":"11344520","expires":"2035-02-20"},{"number":"11351133","expires":"2035-02-20"},{"number":"8546450","expires":"2030-08-09"},{"number":"8679544","expires":"2030-04-23"},{"number":"8999387","expires":"2030-04-23"},{"number":"9017721","expires":"2030-04-23"},{"number":"9173854","expires":"2030-04-23"},{"number":"9180095","expires":"2030-04-23"},{"number":"9180096","expires":"2030-04-23"},{"number":"9186328","expires":"2030-04-23"},{"number":"8217078","expires":"2029-07-10"},{"number":"8618164","expires":"2029-07-10"},{"number":"8741956","expires":"2029-07-10"},{"number":"9370501","expires":"2029-07-10"},{"number":"9375412","expires":"2029-07-10"},{"number":"9415029","expires":"2029-07-10"},{"number":"7662858","expires":"2029-02-24"},{"number":"7884095","expires":"2029-02-24"},{"number":"7939518","expires":"2029-02-24"},{"number":"8110606","expires":"2029-02-24"},{"number":"8623920","expires":"2029-02-24"},{"number":"9561200","expires":"2029-02-24"},{"number":"8252838","expires":"2028-04-21"},{"number":"8563613","expires":"2027-10-17"},{"number":"8871809","expires":"2027-10-17"},{"number":"9066913","expires":"2027-10-17"},{"number":"9101591","expires":"2027-10-17"},{"number":"9132110","expires":"2027-10-17"},{"number":"9168304","expires":"2027-10-17"},{"number":"9168305","expires":"2027-10-17"},{"number":"9220784","expires":"2027-10-17"},{"number":"9339551","expires":"2027-10-17"},{"number":"9339552","expires":"2027-10-17"},{"number":"9539335","expires":"2027-10-17"},{"number":"8946292","expires":"2027-03-22"},{"number":"7759394","expires":"2026-06-16"},{"number":"8097651","expires":"2026-06-16"},{"number":"8927604","expires":"2026-06-16"},{"number":"9827197","expires":"2026-06-16"}],"targets":[{"gene":"ASIC3","target":"Acid-sensing ion channel 3","protein":"Acid-sensing ion channel 3","activityType":"IC50","activityUnit":"","activityValue":4},{"gene":"AKR1B10","target":"Aldo-keto reductase family 1 member B10","protein":"Aldo-keto reductase family 1 member B10","activityType":"IC50","activityUnit":"","activityValue":5.72},{"gene":"AKR1C3","target":"Aldo-keto reductase family 1 member C3","protein":"Aldo-keto reductase family 1 member C3","activityType":"IC50","activityUnit":"","activityValue":5.59},{"gene":"CXCR1","target":"C-X-C chemokine receptor type 1","protein":"C-X-C chemokine receptor type 1","activityType":"IC50","activityUnit":"","activityValue":7.92},{"gene":"MT-CO2","target":"Cytochrome c oxidase subunit 2","protein":"Cytochrome c oxidase subunit 2","activityType":"IC50","activityUnit":"","activityValue":5},{"gene":"CXCL8","target":"Interleukin-8","protein":"Interleukin-8","activityType":"IC50","activityUnit":"","activityValue":8.1},{"gene":"PPARG","target":"Peroxisome proliferator-activated receptor gamma","protein":"Peroxisome proliferator-activated receptor gamma","activityType":"Ki","activityUnit":"","activityValue":6.2},{"gene":"PTGS1","target":"Prostaglandin G/H synthase 1","protein":"Prostaglandin G/H synthase 1","activityType":"IC50","activityUnit":"","activityValue":7.52},{"gene":"PTGS2","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2","activityType":"IC50","activityUnit":"","activityValue":7.7},{"gene":"TRPA1","target":"Transient receptor potential cation channel subfamily A member 1","protein":"Transient receptor potential cation channel subfamily A member 1","activityType":"EC50","activityUnit":"","activityValue":4.25},{"gene":"TRPM3","target":"Transient receptor potential cation channel subfamily M member 3","protein":"Transient receptor potential cation channel subfamily M member 3","activityType":"IC50","activityUnit":"","activityValue":5.2},{"gene":"TTR","target":"Transthyretin","protein":"Transthyretin","activityType":"Kd","activityUnit":"","activityValue":6},{"gene":"UGT1A1","target":"UDP-glucuronosyltransferase 1-1","protein":"UDP-glucuronosyltransferase 1-1","activityType":"Ki","activityUnit":"","activityValue":4.28},{"gene":"UGT1A10","target":"UDP-glucuronosyltransferase 1-10","protein":"UDP-glucuronosyltransferase 1-10","activityType":"Ki","activityUnit":"","activityValue":4.55},{"gene":"UGT1A6","target":"UDP-glucuronosyltransferase 1-6","protein":"UDP-glucuronosyltransferase 1-6","activityType":"Ki","activityUnit":"","activityValue":4.64},{"gene":"UGT1A7","target":"UDP-glucuronosyltransferase 1-7","protein":"UDP-glucuronosyltransferase 1-7","activityType":"Ki","activityUnit":"","activityValue":4.72},{"gene":"UGT1A9","target":"UDP-glucuronosyltransferase 1-9","protein":"UDP-glucuronosyltransferase 1-9","activityType":"Ki","activityUnit":"","activityValue":4.96}],"atcCodes":["D11AX18","M01AB05","M01AB55","M02AA15","S01BC03","S01CC01"],"synonyms":["diclofenac calcium","diclofenac diethylamine","diclofenac hydroxyethylpyrrolidine","diclofenac","diclofenamic acid","diclofenac sodium","diclofenac potassium","diclofenac epolamine"],"approvals":[{"date":"1988-07-28","orphan":false,"company":"","regulator":"FDA"},{"date":"2021-03-23","orphan":false,"company":"Hisamitsu Pharmaceutical Co., Inc","regulator":"PMDA"}],"properties":{"S":{"name":"Water solubility","units":"mg/mL","value":0.0012},"BA":{"name":"Bioavailability","units":"%","value":54},"CL":{"name":"Clearance","units":"mL/min/kg","value":3.5},"Vd":{"name":"Volume of distribution","units":"L/kg","value":0.22},"fu":{"name":"Fraction unbound in plasma","units":"%","value":0.005},"EoM":{"name":"Fraction excreted unchanged in urine","units":"%","value":0.5},"MRTD":{"name":"Maximum Recommended Therapeutic Daily Dose","units":"µM/kg/day","value":10.85321045},"BDDCS":{"name":"Biopharmaceutical Drug Disposition Classification System","units":"","value":2},"t_half":{"name":"Half-life","units":"hours","value":1.4}},"drugClasses":["diclofenac"],"identifiers":{"NUI":"N0000147806","MMSL":"11838","NDDF":"002391","UNII":"144O8QL0L1","VUID":"4019714","CHEBI":"CHEBI:47381","VANDF":"4019378","INN_ID":"3270","RXNORM":"203214","UMLSCUI":"C0012091","ChEMBL_ID":"CHEMBL139","KEGG_DRUG":"D00903","DRUGBANK_ID":"DB00586","PDB_CHEM_ID":" DIF","PUBCHEM_CID":"3033","SNOMEDCT_US":"108515008","IUPHAR_LIGAND_ID":"2714","SECONDARY_CAS_RN":"88170-10-9","MESH_DESCRIPTOR_UI":"D004008","MESH_SUPPLEMENTAL_RECORD_UI":"C000614065"},"indications":[{"name":"Actinic keratosis","source":"DrugCentral","umlsCui":"C0022602","snomedId":201101007},{"name":"Adhesive capsulitis of shoulder","source":"DrugCentral","umlsCui":"C1306835","snomedId":399114005},{"name":"Analgesia in various types of cancer","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Ankylosing spondylitis","source":"DrugCentral","umlsCui":"C0038013","snomedId":9631008},{"name":"Dysmenorrhea","source":"DrugCentral","umlsCui":"C0013390","snomedId":266599000},{"name":"Lumbago","source":"DrugCentral","umlsCui":"C0024031","snomedId":279039007},{"name":"Neckshoulderarm syndrome","source":"DrugCentral","umlsCui":"C0877543","snomedId":""},{"name":"Osteoarthritis","source":"DrugCentral","umlsCui":"C0029408","snomedId":396275006},{"name":"Osteoarthritis in Patients at High Ulcer Risk","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Osteoarthrosis of the Knee","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Pain","source":"DrugCentral","umlsCui":"C0030193","snomedId":22253000},{"name":"Post-Op Ocular Inflammation","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Post-Op Photophobia","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Postoperative Ocular Pain","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Rheumatoid Arthritis in Patient at High Ulcer Risk","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Rheumatoid arthritis","source":"DrugCentral","umlsCui":"C0003873","snomedId":69896004},{"name":"Sprains and Strains","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Tenosynovitis","source":"DrugCentral","umlsCui":"C0039520","snomedId":67801009}],"formulations":[{"form":"AEROSOL, METERED","route":"TOPICAL","status":"unapproved drug other","tradeName":"Diclofenac Sodium"},{"form":"CAPSULE","route":"ORAL","status":"NDA","tradeName":"DICLOFENAC"},{"form":"CAPSULE","route":"ORAL","status":"NDA","tradeName":"Zorvolex"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","status":"ANDA","tradeName":"Diclofenac Potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","status":"ANDA","tradeName":"Diclofenac potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","status":"ANDA","tradeName":"diclofenac potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","status":"NDA","tradeName":"ZIPSOR"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","status":"NDA authorized generic","tradeName":"Diclofenac Potassium"},{"form":"CREAM","route":"TOPICAL","status":"unapproved drug other","tradeName":"CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%"},{"form":"GEL","route":"TOPICAL","status":"ANDA","tradeName":"Aleve Arthritis Pain Gel"}],"offLabelUses":[{"name":"Bursitis","source":"DrugCentral","umlsCui":"C0006444","snomedId":84017003},{"name":"Cystoid macular edema","source":"DrugCentral","umlsCui":"C0024440","snomedId":193387007},{"name":"Prevention of Ocular Surgery-Induced Miosis","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Renal colic","source":"DrugCentral","umlsCui":"C0152169","snomedId":7093002},{"name":"Tendinitis","source":"DrugCentral","umlsCui":"C0039503","snomedId":34840004}],"drugCentralId":865,"drugInteractions":[{"risk":"Significant","description":"DICLOFENAC/DICUMAROL [VA Drug Interaction]","interactingClass":"dicoumarol"},{"risk":"Significant","description":"DICLOFENAC/FLUCONAZOLE [VA Drug Interaction]","interactingClass":"fluconazole"},{"risk":"Significant","description":"DICLOFENAC/LITHIUM [VA Drug Interaction]","interactingClass":"lithium"},{"risk":"Significant","description":"DICLOFENAC/METHOTREXATE [VA Drug Interaction]","interactingClass":"methotrexate"},{"risk":"Significant","description":"DICLOFENAC/PHENPROCOUMON [VA Drug Interaction]","interactingClass":"phenprocoumon"},{"risk":"Significant","description":"DICLOFENAC/VORICONAZOLE [VA Drug Interaction]","interactingClass":"voriconazole"},{"risk":"Significant","description":"DICLOFENAC/WARFARIN [VA Drug Interaction]","interactingClass":"warfarin"}],"contraindications":[{"name":"Acute nephropathy","source":"DrugCentral","umlsCui":"C0268734","snomedId":58574008},{"name":"Alcoholism","source":"DrugCentral","umlsCui":"C0001973","snomedId":7200002},{"name":"Anemia","source":"DrugCentral","umlsCui":"C0002871","snomedId":271737000},{"name":"Asthenia","source":"DrugCentral","umlsCui":"C0004093","snomedId":13791008},{"name":"Asthma","source":"DrugCentral","umlsCui":"C0004096","snomedId":195967001},{"name":"Blood coagulation disorder","source":"DrugCentral","umlsCui":"C0005779","snomedId":64779008},{"name":"Bloody Vomit","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Body fluid retention","source":"DrugCentral","umlsCui":"C0268000","snomedId":43498006},{"name":"Cardiovascular event risk","source":"DrugCentral","umlsCui":"C1273410","snomedId":395112001},{"name":"Cerebrovascular accident","source":"DrugCentral","umlsCui":"C0038454","snomedId":230690007},{"name":"Chronic heart failure","source":"DrugCentral","umlsCui":"C0264716","snomedId":48447003},{"name":"Corneal Infiltrates","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Corneal degeneration","source":"DrugCentral","umlsCui":"C0155118","snomedId":111521006},{"name":"Corneal erosion","source":"DrugCentral","umlsCui":"C0392163","snomedId":50792001},{"name":"Corneal ulcer","source":"DrugCentral","umlsCui":"C0010043","snomedId":91514001},{"name":"Coronary artery bypass graft","source":"DrugCentral","umlsCui":"C0010055","snomedId":232717009},{"name":"Dehydration","source":"DrugCentral","umlsCui":"C0011175","snomedId":34095006},{"name":"Deliveries by cesarean","source":"DrugCentral","umlsCui":"C1384674","snomedId":200144004},{"name":"Diabetes mellitus","source":"DrugCentral","umlsCui":"C0011849","snomedId":73211009},{"name":"Disease of liver","source":"DrugCentral","umlsCui":"C0023895","snomedId":235856003},{"name":"Disorder of cardiovascular system","source":"DrugCentral","umlsCui":"C0007222","snomedId":49601007},{"name":"Drug-induced hepatitis","source":"DrugCentral","umlsCui":"C1262760","snomedId":235876009},{"name":"Duodenal ulcer disease","source":"DrugCentral","umlsCui":"C0013295","snomedId":51868009},{"name":"Edema","source":"DrugCentral","umlsCui":"C0013604","snomedId":267038008},{"name":"Gastrointestinal hemorrhage","source":"DrugCentral","umlsCui":"C0017181","snomedId":74474003},{"name":"Gastrointestinal perforation","source":"DrugCentral","umlsCui":"C0151664","snomedId":51875005},{"name":"Gastrointestinal ulcer","source":"DrugCentral","umlsCui":"C0237938","snomedId":40845000},{"name":"Gynecological Surgery","source":"DrugCentral","umlsCui":"","snomedId":""},{"name":"Hepatic failure","source":"DrugCentral","umlsCui":"C0085605","snomedId":59927004},{"name":"Hypertensive disorder","source":"DrugCentral","umlsCui":"C0020538","snomedId":38341003},{"name":"Infection of skin AND/OR subcutaneous tissue","source":"DrugCentral","umlsCui":"C0178299","snomedId":19824006},{"name":"Inflammatory bowel disease","source":"DrugCentral","umlsCui":"C0021390","snomedId":24526004},{"name":"Keratitis","source":"DrugCentral","umlsCui":"C0022568","snomedId":5888003},{"name":"Liver function tests abnormal","source":"DrugCentral","umlsCui":"C0151766","snomedId":166603001},{"name":"Myocardial infarction","source":"DrugCentral","umlsCui":"C0027051","snomedId":22298006},{"name":"Open wound","source":"DrugCentral","umlsCui":"C0332798","snomedId":125643001},{"name":"Peptic ulcer","source":"DrugCentral","umlsCui":"C0030920","snomedId":13200003},{"name":"Perforation of cornea","source":"DrugCentral","umlsCui":"C0339293","snomedId":74895004},{"name":"Pregnancy, function","source":"DrugCentral","umlsCui":"C0032961","snomedId":289908002},{"name":"Skin ulcer","source":"DrugCentral","umlsCui":"C0037299","snomedId":46742003},{"name":"Smokes tobacco daily","source":"DrugCentral","umlsCui":"C3266136","snomedId":449868002},{"name":"Thromboembolic disorder","source":"DrugCentral","umlsCui":"C0040038","snomedId":371039008},{"name":"Uterine Rupture in Pregnancy","source":"DrugCentral","umlsCui":"","snomedId":""}]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06029296","phase":"EARLY_PHASE1","title":"Diclofenac as a KMO Inhibitor","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2024-07-31","conditions":"Alcohol Use Disorder","enrollment":12},{"nctId":"NCT07493226","phase":"NA","title":"Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis","status":"RECRUITING","sponsor":"Konya Beyhekim Training and Research Hospital","startDate":"2026-04-01","conditions":"Frozen Shoulder, Adhesive Capsulitis, Shoulder Pain","enrollment":120},{"nctId":"NCT06252441","phase":"PHASE1, PHASE2","title":"Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-03-16","conditions":"Post ERCP Pancreatitis","enrollment":46},{"nctId":"NCT07071012","phase":"NA","title":"Pain Control After Open Radical Nephrectomy: Thoracic Paravertebral Block Versus External Oblique Intercostal Block","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2025-08-01","conditions":"Nephrectomy, Pain Scores, Paravertebral Block","enrollment":98},{"nctId":"NCT07475663","phase":"PHASE3","title":"Counterpain PXM Versus Diclofenac Versus Piroxicam","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2025-11-04","conditions":"Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee","enrollment":180},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT06959394","phase":"NA","title":"Comparison of the Effectiveness of Therapeutic Ultrasound and Phonophoresis in Chronic Low Back Pain","status":"COMPLETED","sponsor":"KTO Karatay University","startDate":"2025-09-01","conditions":"Low Back Pain","enrollment":60},{"nctId":"NCT05761015","phase":"PHASE4","title":"Helping Osteoarthritis Patients to Walk With NSAID","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-12-14","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Pain","enrollment":55},{"nctId":"NCT07212647","phase":"NA","title":"Home-Based Strategies for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2025-10-09","conditions":"Knee Osteoarthritis, Knee Osteoarthritis (Knee OA)","enrollment":83},{"nctId":"NCT07079969","phase":"PHASE2","title":"Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"Knee Pain Chronic","enrollment":32},{"nctId":"NCT06373978","phase":"PHASE4","title":"NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-08-12","conditions":"Elbow Pain, Chronic Pain","enrollment":92},{"nctId":"NCT06731270","phase":"PHASE2","title":"Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-04-09","conditions":"Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8","enrollment":20},{"nctId":"NCT06636227","phase":"PHASE1","title":"Diclofenac Dose Response Study","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2024-12-01","conditions":"Alcohol Use Disorder (AUD), Alcohol-Related Disorders","enrollment":24},{"nctId":"NCT07379762","phase":"PHASE4","title":"Intramuscular Versus Rectal Diclofenac for Pain Relief After Cesarean Section in Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2025-02-01","conditions":"Cesarean Section Pain, Diclofenac, Suppository","enrollment":60},{"nctId":"NCT07358065","phase":"NA","title":"Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Putian University","startDate":"2026-01-01","conditions":"Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery","enrollment":135},{"nctId":"NCT02636569","phase":"PHASE2","title":"Topical Chemoprevention of Skin Cancer Biomarkers","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2017-10-25","conditions":"Non-melanoma Skin Cancer","enrollment":24},{"nctId":"NCT06379893","phase":"PHASE4","title":"A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-04-25","conditions":"Pain","enrollment":196},{"nctId":"NCT06693648","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amzell","startDate":"2025-02-18","conditions":"Osteoarthritis of Knee, Osteoarthritis, Knee","enrollment":540},{"nctId":"NCT07244029","phase":"NA","title":"Aescin-Based Herbal Extract (Reparil) for Postoperative Sequelae After Mandibular Third Molar Surgery","status":"RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-01-01","conditions":"Postoperative Pain, Facial Swelling, Trismus","enrollment":100},{"nctId":"NCT07329790","phase":"","title":"Indian National Study to Assess Incidence and Severity of Post-ERCP Pancreatitis After Following SOP","status":"NOT_YET_RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2026-01-10","conditions":"ERCP","enrollment":2366},{"nctId":"NCT07328893","phase":"PHASE4","title":"Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Tata Main Hospital","startDate":"2025-12-27","conditions":"Analgesia; Postoperative","enrollment":106},{"nctId":"NCT03756961","phase":"NA","title":"Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2019-05-01","conditions":"Obesity, Pain, Postoperative","enrollment":220},{"nctId":"NCT06729073","phase":"PHASE1","title":"Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.","status":"COMPLETED","sponsor":"Amzell","startDate":"2024-11-29","conditions":"Healthy Volunteer","enrollment":34},{"nctId":"NCT07304882","phase":"PHASE3","title":"A Comparison of Recovery After Impacted Wisdom Tooth Removal","status":"COMPLETED","sponsor":"University of Science and Technology, Yemen","startDate":"2023-11-30","conditions":"Impacted Mandibular Third Molar Extraction, Post Operative Complications","enrollment":24},{"nctId":"NCT06942702","phase":"NA","title":"Efficacy of Genicular Block on Total Knee Arthroplasty Surgery","status":"NOT_YET_RECRUITING","sponsor":"Mersin University","startDate":"2025-12-20","conditions":"Total Knee Anthroplasty, Genicular Nerves Block","enrollment":44},{"nctId":"NCT06685445","phase":"NA","title":"Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2024-10-18","conditions":"Post-thoracotomy Pain","enrollment":60},{"nctId":"NCT04091022","phase":"PHASE2","title":"Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-01-18","conditions":"Non-melanoma Skin Cancer","enrollment":64},{"nctId":"NCT06632184","phase":"PHASE4","title":"Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-12-01","conditions":"Postoperative Pain Management, Laparoscopic Cholecystectomy, Ondansetron","enrollment":40},{"nctId":"NCT07271654","phase":"NA","title":"Can Pretreatment With Analgesics Reduce Postendodontic Pain?","status":"COMPLETED","sponsor":"College of Physicians and Surgeons Pakistan","startDate":"2025-08-01","conditions":"Pulpitis - Irreversible","enrollment":160},{"nctId":"NCT07083063","phase":"PHASE4","title":"Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis","status":"RECRUITING","sponsor":"National Cheng-Kung University Hospital","startDate":"2025-09-15","conditions":"Pancreatitis","enrollment":440},{"nctId":"NCT07267182","phase":"NA","title":"Gabapentin and Diclofenac Sodium Comparison for Post-Operative Pain Relief","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2022-08-01","conditions":"Postoperative Pain","enrollment":240},{"nctId":"NCT07117318","phase":"NA","title":"Rectal NSAIDs With/Without PD Stent for PEP Prevention","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2025-07-01","conditions":"Post-ERCP Acute Pancreatitis, Non-steroid Anti-inflammatory Drugs, Pancreatic Duct Stent Placement","enrollment":1278},{"nctId":"NCT07071441","phase":"NA","title":"Indomethacin vs Diclofenac for Preventing PEP","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2025-06-01","conditions":"ERCP, Pancreatitis, Non-steroidal Anti-inflammatory (NSAID)","enrollment":4050},{"nctId":"NCT07262463","phase":"NA","title":"Effect of Traction-Pressure-Release and Manual Pressure on Intramuscular Injection Pain","status":"COMPLETED","sponsor":"Melek Sahin","startDate":"2024-12-20","conditions":"Intramuscular Injection Pain","enrollment":174},{"nctId":"NCT07248332","phase":"PHASE1","title":"The Efface of Lidocaine vs. Magnesium Sulphate in the Management of Pain After Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2024-01-18","conditions":"Laparoscopic Cholecystectomy Surgery, Postoperative Pain Management","enrollment":168},{"nctId":"NCT07248384","phase":"PHASE1","title":"The Efface of Ketamine vs. Lidocaine in the Management of Pain After Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2023-07-15","conditions":"Pain, Postoperative","enrollment":76},{"nctId":"NCT07248358","phase":"PHASE1","title":"The Efface of Ketamine vs. Magnesium Sulphate in the Management of Pain After Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2023-06-15","conditions":"Laparoscopic Cholecystectomy Surgery, Postoperative Pain Management","enrollment":78},{"nctId":"NCT07237620","phase":"NA","title":"The Effect of Different Intracanal Medicaments on Periapical Lesion Healing","status":"RECRUITING","sponsor":"Mustafa Kemal University","startDate":"2025-09-15","conditions":"Periapical Lesion Healing, Apical Periodontitis","enrollment":60},{"nctId":"NCT06298383","phase":"NA","title":"The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-06-15","conditions":"Symptomatic Irreversible Pulpitis","enrollment":120},{"nctId":"NCT07233694","phase":"NA","title":"IM İnjection-PAIN-Cold Spray and Stress Ball","status":"NOT_YET_RECRUITING","sponsor":"Erzincan Binali Yildirim Universitesi","startDate":"2025-11-25","conditions":"Pain, Procedural, Acute Pain, Injection Site","enrollment":66},{"nctId":"NCT07104370","phase":"NA","title":"Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws","status":"RECRUITING","sponsor":"Semmelweis University","startDate":"2025-09-29","conditions":"Edentulous Alveolar Ridge, Edentulous Alveolar Ridge Atrophy","enrollment":30},{"nctId":"NCT07203651","phase":"NA","title":"Comparison Between Diclofenac and Sterile Water Injection for Relief of Labour Associated Bachache","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pakistan Institute of Medical Sciences","startDate":"2025-01-01","conditions":"Labour Analgesia","enrollment":100},{"nctId":"NCT05211154","phase":"PHASE4","title":"Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine","status":"TERMINATED","sponsor":"Danish Headache Center","startDate":"2022-05-05","conditions":"Migraine With Aura, Migraine Without Aura","enrollment":300},{"nctId":"NCT07060976","phase":"NA","title":"To Check Dermatological Safety of Test Products by 24 Hours Patch Testing","status":"COMPLETED","sponsor":"Novamed Laboratories Pvt. Ltd.","startDate":"2025-07-21","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT07177560","phase":"","title":"Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)","status":"COMPLETED","sponsor":"Gazi University","startDate":"2023-07-30","conditions":"Colorectal Cancer, Gastric Cancer (GC), Capecitabine","enrollment":151},{"nctId":"NCT07178639","phase":"NA","title":"Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery","status":"RECRUITING","sponsor":"Nemocnice Kolín","startDate":"2025-08-01","conditions":"Macular Oedema, Cataract Surgery, NSAID (Non-Steroidal Anti-Inflammatory Drug)","enrollment":150},{"nctId":"NCT05827003","phase":"NA","title":"Effects of Exercise Versus Topical Agents on Knee Osteoarthritis","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-04-15","conditions":"Osteo Arthritis Knee","enrollment":79},{"nctId":"NCT05752526","phase":"PHASE1","title":"A Study of Diclofenac Gel in Women With Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2023-05-19","conditions":"Dysmenorrhea Primary","enrollment":42},{"nctId":"NCT04683627","phase":"PHASE3","title":"A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee","status":"COMPLETED","sponsor":"Noven Pharmaceuticals, Inc.","startDate":"2020-12-29","conditions":"Osteoarthritis Pain of the Knee","enrollment":370},{"nctId":"NCT05877027","phase":"NA","title":"Exercise vs. Topical Diclofenac vs. PRP","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-03-20","conditions":"Gonarthrosis","enrollment":82},{"nctId":"NCT07145645","phase":"PHASE3","title":"Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-09-02","conditions":"Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle","enrollment":60},{"nctId":"NCT06632015","phase":"NA","title":"Effect of DCS on Post-Endodontic Pain","status":"COMPLETED","sponsor":"Mustafa Kemal University","startDate":"2024-01-22","conditions":"Post Endodontic Pain","enrollment":90},{"nctId":"NCT07131527","phase":"NA","title":"Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-07-14","conditions":"Cholecystitis, Chronic","enrollment":60},{"nctId":"NCT03595150","phase":"PHASE2, PHASE3","title":"Diclofenac for Prevention of Post-ERC Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2026-01-01","conditions":"Common Bile Duct Diseases","enrollment":1000},{"nctId":"NCT06439251","phase":"PHASE1, PHASE2","title":"Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome.","status":"COMPLETED","sponsor":"University of Lahore","startDate":"2023-10-18","conditions":"Patellofemoral Pain Syndrome","enrollment":68},{"nctId":"NCT07106333","phase":"NA","title":"Assessment of Ozone Therapy for Management of Post-Extraction Localized Alveolar Osteitis","status":"NOT_YET_RECRUITING","sponsor":"Menoufia University","startDate":"2025-08-01","conditions":"Alveolar Osteitis","enrollment":40},{"nctId":"NCT06012097","phase":"PHASE4","title":"Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-06-04","conditions":"De Quervain Disease","enrollment":70},{"nctId":"NCT07101016","phase":"NA","title":"Effect of Local Use of Non-steroidal Anti-inflammatory Agent (Diclofenac Sodium) With and Without Hyaluronidase on Post-surgical Pain and Swelling","status":"NOT_YET_RECRUITING","sponsor":"Mariam Hesham Mahmoud Abdelfattah Eissa","startDate":"2025-08-01","conditions":"Root End Resection, Periapical Lesion, Single Rooted Teeth","enrollment":44},{"nctId":"NCT05100017","phase":"NA","title":"Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2021-09-30","conditions":"Kidney Calculi, Kidney Diseases, Nephrolithiasis","enrollment":126},{"nctId":"NCT07063160","phase":"NA","title":"Effect of Acupressure Therapy on Pain, Fear, and Post-Injection Satisfaction in Patients Undergoing IM Injection","status":"COMPLETED","sponsor":"Eastern Mediterranean University","startDate":"2024-11-15","conditions":"Injection Fear, Injection Site","enrollment":68},{"nctId":"NCT06937853","phase":"NA","title":"Effect of Genetic Polymorphisms on Response to Preoperative NSAIDs in Endodontic Postoperative Pain Management","status":"RECRUITING","sponsor":"Ataturk University","startDate":"2024-05-10","conditions":"Postoperative Pain","enrollment":200},{"nctId":"NCT07043699","phase":"NA","title":"Effect of Phonophoresis Versus Iontophoresis in the Treatment of Perimenopausal Plantar Fasciitis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-01","conditions":"Plantar Fasciitis","enrollment":42},{"nctId":"NCT07040709","phase":"NA","title":"Efficacy of Peripheral Nerve Blocks in Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Tokat Gaziosmanpasa University","startDate":"2025-06-08","conditions":"Postoperative Pain Following Knee Arthroplasty","enrollment":86},{"nctId":"NCT06918340","phase":"PHASE4","title":"Evaluation of Analgesic Efficacy of Lidocaine and Diclofenac Spray in Radial Artery Blood Gas Sampling by Visual Analogue Scale and Perfusion Index","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2024-11-01","conditions":"Blood Gas Analysis, Topical Analgesia","enrollment":150},{"nctId":"NCT07016451","phase":"EARLY_PHASE1","title":"Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis","status":"ENROLLING_BY_INVITATION","sponsor":"Thanakrit Visuthikosol","startDate":"2024-04-02","conditions":"Radiation Cystitis","enrollment":40},{"nctId":"NCT06905561","phase":"NA","title":"Topical Diclofenac for Prevention of Radiation-induced Dermatitis","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Hainan Medical University","startDate":"2025-02-13","conditions":"Head and Neck Tumor, Breast Cancer","enrollment":156},{"nctId":"NCT02193620","phase":"PHASE2, PHASE3","title":"Study of PHN131 in Patients After Surgery","status":"COMPLETED","sponsor":"PhytoHealth Corporation","startDate":"2013-04-30","conditions":"Analgesia Disorder","enrollment":106},{"nctId":"NCT07004166","phase":"NA","title":"Effects of TPR and Z Techniques on Pain and Drug Leakage in Intramuscular Injections","status":"RECRUITING","sponsor":"Cumhuriyet University","startDate":"2025-06-15","conditions":"Muscle Pain, Injection Site Pain","enrollment":76},{"nctId":"NCT06207253","phase":"PHASE2, PHASE3","title":"The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament","status":"RECRUITING","sponsor":"British University In Egypt","startDate":"2025-11","conditions":"Endodontic Disease, Pulp Disease, Dental, Intracanal Medication","enrollment":48},{"nctId":"NCT06982755","phase":"PHASE1, PHASE2","title":"Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine","startDate":"2025-06-01","conditions":"Acute Abdominal Pain, Acupuncture Therapy, Acupuncture","enrollment":176},{"nctId":"NCT06976151","phase":"NA","title":"Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-05-20","conditions":"Autoimmune Diseases","enrollment":52},{"nctId":"NCT05882812","phase":"PHASE2","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-03","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":200},{"nctId":"NCT06967363","phase":"","title":"Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-15","conditions":"Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain","enrollment":360},{"nctId":"NCT05050448","phase":"PHASE1, PHASE2","title":"Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2021-08-01","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT06954181","phase":"NA","title":"Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods","status":"COMPLETED","sponsor":"HALEON","startDate":"2025-03-26","conditions":"Healthy Participants","enrollment":33},{"nctId":"NCT06637111","phase":"NA","title":"Ultrasound Guidance of Office Hysteroscopy in Patients With History of Failure of Office Hysteroscopy Due to Cervical Stenosis.","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-10-30","conditions":"Hysteroscopy","enrollment":58},{"nctId":"NCT06752486","phase":"PHASE1","title":"Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study","status":"RECRUITING","sponsor":"Research Institute of Ophthalmology, Egypt","startDate":"2024-12-01","conditions":"Pain After Photorefractive Keratectomy, VAS Will be Used to Assess Pain Postoperative","enrollment":64},{"nctId":"NCT06943092","phase":"NA","title":"Piroxicam Versus Diclofenac for Post Caesarean Section Analgesia","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2020-01-11","conditions":"Analgesia, Post Caserean","enrollment":108},{"nctId":"NCT05267379","phase":"","title":"An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2022-03-01","conditions":"Post-ERCP Acute Pancreatitis","enrollment":700},{"nctId":"NCT06158620","phase":"PHASE1, PHASE2","title":"Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-03-01","conditions":"Post Operative Pain, Urolithiasis, Ureter Calculi","enrollment":80},{"nctId":"NCT05968482","phase":"PHASE1","title":"Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants","status":"COMPLETED","sponsor":"Amzell","startDate":"2023-07-11","conditions":"Healthy","enrollment":74},{"nctId":"NCT06307106","phase":"NA","title":"Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2024-01-14","conditions":"Acute Post Operative Pain","enrollment":150},{"nctId":"NCT06911437","phase":"","title":"Clinical Study on the Combination of Xiaoyu Zhitong Formula and Lymphatic Drainage Technique to Improve the Symptoms of Knee Pain and Swelling in Cold Dampness Obstruction Type","status":"ENROLLING_BY_INVITATION","sponsor":"tang jie","startDate":"2024-10-10","conditions":"Knee Osteoarthritis (OA)","enrollment":100},{"nctId":"NCT06795594","phase":"NA","title":"Effectiveness of Cheek Acupuncture Therapy for Pain Control After Cesarean Delivery","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2025-01-05","conditions":"Acupuncture Analgesia","enrollment":80},{"nctId":"NCT06574191","phase":"NA","title":"The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2025-01-29","conditions":"Knee Osteoarthritis","enrollment":220},{"nctId":"NCT06857110","phase":"NA","title":"\"Supracondylar Radial Nerve Block Guided by Ultrasound Versus Hematoma Block for Analgesic Management in Closed Reduction of Distal Radius Fractures\"","status":"RECRUITING","sponsor":"Hospital Universitario San Ignacio","startDate":"2024-06-01","conditions":"Distal Radius Fracture","enrollment":50},{"nctId":"NCT06743386","phase":"NA","title":"Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP )","status":"NOT_YET_RECRUITING","sponsor":"French Society of Digestive Endoscopy","startDate":"2025-04","conditions":"Pancreatic Adenocarcinoma","enrollment":30},{"nctId":"NCT06866587","phase":"NA","title":"Cervical Dizziness in Patients With Acute Non-specific Neck Pain","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2019-04-14","conditions":"Dizziness, Neck Pain, Elastography","enrollment":121},{"nctId":"NCT06864078","phase":"NA","title":"IUCD Insertion in Patients Delivered by Cesarean Section","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-09-10","conditions":"IUD","enrollment":128},{"nctId":"NCT06510062","phase":"PHASE1","title":"Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2024-07-22","conditions":"Measurement of Circulation on Anatomical Locations of the Body","enrollment":67},{"nctId":"NCT06257537","phase":"PHASE2","title":"Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2024-10-01","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":300},{"nctId":"NCT06731556","phase":"PHASE3","title":"Analgesic Effects of Intranasal Diclofenac Sodium, Ibuprofen, and Paracetamol in Pediatric Tonsillectomy Cases","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2024-12-15","conditions":"Tonsil Disease, Pain Management, Intranasal Drug Administration","enrollment":60},{"nctId":"NCT05883241","phase":"PHASE1","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-01","conditions":"Bone Fracture, Fresh Fracture","enrollment":90},{"nctId":"NCT05254574","phase":"PHASE1","title":"Sustained Acoustic Medicine for Osteoarthritis Pain","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2022-02-14","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT06845930","phase":"NA","title":"Rectal Versus Intramuscular Diclofenac for Pain Relief Following Caesarean Section","status":"COMPLETED","sponsor":"Assumpta Nnenna Nweke","startDate":"2021-04-19","conditions":"Painrelief, Postoperative","enrollment":60},{"nctId":"NCT02406014","phase":"PHASE4","title":"Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-04","conditions":"Actinic Keratosis (AK)","enrollment":502},{"nctId":"NCT06829030","phase":"PHASE1, PHASE2","title":"Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain.","status":"ENROLLING_BY_INVITATION","sponsor":"Aksaray University Training and Research Hospital","startDate":"2024-07-15","conditions":"Low Back Pain, Mechanical","enrollment":150},{"nctId":"NCT06824025","phase":"EARLY_PHASE1","title":"Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following Subarachnoid Block in Parturient Undergoing Elective Cesarean Section. A Randomized, Clinical Trial.","status":"NOT_YET_RECRUITING","sponsor":"Minia University","startDate":"2025-02-20","conditions":"Post-Dural Puncture Headache","enrollment":111},{"nctId":"NCT05387525","phase":"PHASE4","title":"A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Almirall, S.A.","startDate":"2022-10-24","conditions":"Keratosis, Actinic","enrollment":447},{"nctId":"NCT05312645","phase":"PHASE3","title":"Diclofenac Gel in the Treatment of Cervicogenic Headache","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2023-12","conditions":"Cervicogenic Headache","enrollment":0}],"_emaApprovals":[{"date":"","name":"Arthrotec","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[{"url":"https://www.gminsights.com/industry-analysis/anti-inflammatory-drugs-market","date":"2026-04-07","type":"news","title":"Anti-inflammatory Drugs Market Size & Forecast 2026–2035","source":"www.gminsights.com"},{"url":"https://www.getreskilled.com/pharmaceutical-companies/","date":"2026-04-07","type":"news","title":"Top 15 Pharmaceutical Companies in the World 2025 - GetReskilled","source":"www.getreskilled.com"},{"url":"https://www.sanofi.com/assets/dotcom/pressreleases/2025/2025-10-24-05-30-00-3172594-en.pdf","date":"2026-04-07","type":"news","title":"[PDF] Q3: continued sales and earnings progress - Sanofi","source":"www.sanofi.com"},{"url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/020607Orig1s043ltr.pdf","date":"2026-04-07","type":"news","title":"[PDF] Arthrotec (diclofenac sodium and misoprostol) delayed-release tablets","source":"www.accessdata.fda.gov"},{"url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020607Orig1s041ltr.pdf","date":"2026-04-07","type":"news","title":"[PDF] NDA 20607-S41 SUPPLEMENT APPROVAL Pfizer Inc. Attention","source":"www.accessdata.fda.gov"}],"manufacturing":[{"role":"Manufacturer","site":"Pfizer Laboratories Div Pfizer Inc","location":"","operator":"Pfizer Laboratories Div Pfizer Inc"}],"molecularData":{"oral":true,"chemblId":"CHEMBL1034","moleculeType":"Small molecule","molecularWeight":"318.14"},"administration":{"route":"Topical","formulation":"diclofenac sodium 10 MG/ML Topical Cream [Surpass Anti-Inflammatory]; diclofenac sodium 50 MG / misoprostol 0.2 MG Delayed Release Oral Tablet [Arthrotec]; diclofenac sodium 75 MG / misoprostol 0.2 MG Delayed Release Oral Tablet [Arthrotec]","formulations":[{"form":"AEROSOL, METERED","route":"TOPICAL","tradeName":"Diclofenac Sodium"},{"form":"CAPSULE","route":"ORAL","tradeName":"DICLOFENAC"},{"form":"CAPSULE","route":"ORAL","tradeName":"Zorvolex"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","tradeName":"Diclofenac Potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","tradeName":"Diclofenac potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","tradeName":"diclofenac potassium"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","tradeName":"ZIPSOR"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","tradeName":"Diclofenac Potassium"},{"form":"CREAM","route":"TOPICAL","tradeName":"CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%"},{"form":"GEL","route":"TOPICAL","tradeName":"Aleve Arthritis Pain Gel"}]},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"NUI":"N0000147806","MMSL":"11838","NDDF":"002391","UNII":"144O8QL0L1","VUID":"4019714","CHEBI":"CHEBI:47381","VANDF":"4019378","INN_ID":"3270","RXNORM":"203214","UMLSCUI":"C0012091","chemblId":"CHEMBL1034","ChEMBL_ID":"CHEMBL139","KEGG_DRUG":"D00903","DRUGBANK_ID":"DB00586","PDB_CHEM_ID":" DIF","PUBCHEM_CID":"3033","SNOMEDCT_US":"108515008","IUPHAR_LIGAND_ID":"2714","SECONDARY_CAS_RN":"88170-10-9","MESH_DESCRIPTOR_UI":"D004008","MESH_SUPPLEMENTAL_RECORD_UI":"C000614065"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"notes":"","period":"1980-present","_source":"Wikipedia","companyName":"Searle","relationship":"Originator"},{"notes":"Acquired Searle in 1982","period":"1982-present","_source":"Wikipedia","companyName":"Pfizer","relationship":"Acquirer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.4 hours","clearance":"3.5 mL/min/kg","bioavailability":"54.0%","fractionUnbound":"0.005%","volumeOfDistribution":"0.22 L/kg"},"publicationCount":3452,"therapeuticAreas":["Oncology"],"atcClassification":{"source":"DrugCentral","atcCode":"D11AX18","allCodes":["D11AX18","M01AB05","M01AB55","M02AA15","S01BC03","S01CC01"]},"biosimilarFilings":[],"commercialAnalysis":{"text":"**Commercial Analysis: Arthrotec (Diclofenac Sodium) by Pfizer**\n\nArthrotec, a combination of diclofenac sodium and misoprostol, is an NSAID used to treat various conditions, including actinic keratosis, adhesive capsulitis of the shoulder, and ankylosing spondylitis. According to the anti-inflammatory drugs market report by Global Market Insights Inc. [GMI5976, February 2026], the global anti-inflammatory drugs market is expected to grow from USD 141.3 billion in 2026 to USD 293.4 billion in 2035, with a CAGR of 8.5%. However, Arthrotec's market position and revenue trajectory are not explicitly stated in the provided sources.\n\nThe competitive landscape is dominated by AbbVie, which led the market with over 11% market share in 2025 [GetReskilled, 2025]. Other leading players include Johnson & Johnson, Sanofi, F. Hoffmann La Roche, and Novartis, which collectively held a market share of 45% [GMI5976, February 2026]. Sanofi's Q3 2025 sales report shows a 7.0% growth at CER, driven by launches such as ALTUVIIIO and Ayvakit [Sanofi, October 24, 2025]. However, the report does not provide specific data on Arthrotec's sales or market share.\n\nKey upcoming catalysts for Arthrotec include patent cliffs and potential label expansions. However, limited data is available on these topics. The pipeline landscape is also not explicitly discussed in the provided sources.\n\nIn conclusion, while Arthrotec is a part of the anti-inflammatory drugs market, which is expected to grow significantly, its current market position and revenue trajectory are not explicitly stated. The competitive landscape is dominated by other players, and limited data is available on upcoming catalysts.","model":"llama-3.1-8b (Groq)","sources":[{"url":"https://www.gminsights.com/industry-analysis/anti-inflammatory-drugs-market","date":"","title":"Anti-inflammatory Drugs Market Size & Forecast 2026–2035","source":"www.gminsights.com"},{"url":"https://www.getreskilled.com/pharmaceutical-companies/","date":"","title":"Top 15 Pharmaceutical Companies in the World 2025 - GetReskilled","source":"www.getreskilled.com"},{"url":"https://www.sanofi.com/assets/dotcom/pressreleases/2025/2025-10-24-05-30-00-3172594-en.pdf","date":"","title":"[PDF] Q3: continued sales and earnings progress - Sanofi","source":"www.sanofi.com"}],"disclaimer":"AI-generated analysis based on public sources. Verify with primary sources for investment decisions.","generatedDate":"2026-04-07"},"recentPublications":[{"date":"2026 Mar 25","pmid":"41895492","title":"Polysaccharide-based smart copolymeric hydrogel from chia seeds: Fabrication, pH-responsiveness, sustained drug release, and acute toxicity studies.","journal":"International journal of biological macromolecules"},{"date":"2026 Mar 3","pmid":"41893296","title":"Correction: Ning et al. Orodispersible Membranes from a Modified Coaxial Electrospinning for Fast Dissolution of Diclofenac Sodium. Membranes 2021, 11, 802.","journal":"Membranes"},{"date":"2026 Mar 23","pmid":"41870220","title":"Engineered MnO(2)/UiO-66-x Heterostructure with Tailored Interfaces for Efficient Capture of NSAIDs: Performance and Mechanistic Insights.","journal":"Langmuir : the ACS journal of surfaces and colloids"},{"date":"2026","pmid":"41837191","title":"Chronic nonbacterial osteomyelitis: a typical case and review.","journal":"Frontiers in pediatrics"},{"date":"2026 May 15","pmid":"41832027","title":"Development of a cationic bionanocomplex from N-aryl-chitosan derivatives for controlled drug release.","journal":"Carbohydrate polymers"}],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"genericManufacturers":["AMNEAL PHARMS","PADAGIS ISRAEL","ACTAVIS LABS FL INC","SUN PHARMA CANADA","LUPIN LTD","ACTAVIS MID ATLANTIC","ACTAVIS ELIZABETH","CARLSBAD","ALTAIRE PHARMS INC"],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"approved","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"1988","enrichmentLevel":3,"visitCount":9,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-09-16T00:00:00.000Z","mah":"ACTAVIS LABS FL INC","brand_name_local":null,"application_number":"ANDA201089"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-11-16T00:00:00.000Z","mah":"ALTAIRE PHARMS INC","brand_name_local":null,"application_number":"ANDA203383"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2021-08-24T00:00:00.000Z","mah":"LUPIN LTD","brand_name_local":null,"application_number":"ANDA204132"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-09-21T00:00:00.000Z","mah":"LUPIN PHARMS","brand_name_local":null,"application_number":"ANDA208021"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-11-14T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":null,"application_number":"ANDA206493"},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"patentsNormalised":[{"patent_number":"8097651","territory":"US","patent_type":null,"expiry_date":"2026-06-16T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8927604","territory":"US","patent_type":null,"expiry_date":"2026-06-16T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9827197","territory":"US","patent_type":null,"expiry_date":"2026-06-16T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"7759394","territory":"US","patent_type":null,"expiry_date":"2026-06-16T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8946292","territory":"US","patent_type":null,"expiry_date":"2027-03-22T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9168305","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9132110","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9101591","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9066913","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8871809","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8563613","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9539335","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9339552","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9339551","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9168304","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9220784","territory":"US","patent_type":null,"expiry_date":"2027-10-17T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8252838","territory":"US","patent_type":null,"expiry_date":"2028-04-21T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"7662858","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"7884095","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"7939518","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8110606","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8623920","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9561200","territory":"US","patent_type":null,"expiry_date":"2029-02-24T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8741956","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8618164","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8217078","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9370501","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9415029","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9375412","territory":"US","patent_type":null,"expiry_date":"2029-07-10T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9017721","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8999387","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8679544","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9186328","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9180096","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9180095","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"9173854","territory":"US","patent_type":null,"expiry_date":"2030-04-23T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"8546450","territory":"US","patent_type":null,"expiry_date":"2030-08-09T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"11344520","territory":"US","patent_type":null,"expiry_date":"2035-02-20T00:00:00.000Z","status":"active","paragraph_iv_filed":false},{"patent_number":"11351133","territory":"US","patent_type":null,"expiry_date":"2035-02-20T00:00:00.000Z","status":"active","paragraph_iv_filed":false}],"pricingByCountry":[{"country_code":"Un","currency":"USD","price_amount":"691.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"691.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"691.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"691.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"691.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":8,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:39:08.661369+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}